Skip to content

Type 2 diabetes and insulin resistance were linked to cognitive difficulties in Parkinson's disease

A systematic review identified associations with poorer cognition. It does not establish that these metabolic conditions cause cognitive decline or dementia in people with Parkinson's disease.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The clinical evidence suggested that type 2 diabetes and insulin resistance were associated with poorer cognitive outcomes in Parkinson's disease. Higher levels of the blood sugar marker HbA1c were also linked to poorer cognition and dementia risk. These observations do not show that lowering blood sugar prevents either outcome in this population.

Keep in mind

The review combines different observational designs with non-human research. The abstract calls for larger samples, additional clinical variables and systematic follow-up, leaving causal direction and the role of treatment unresolved.

What the clinical studies measured

Studies commonly assessed cognition using MoCA and MMSE tests, reporting worse performance among participants with type 2 diabetes. Cognitive test scores and a dementia diagnosis are distinct outcomes; an association with either does not establish causation.

What experiments can contribute

Non-human studies reported biological changes accompanying metabolic dysfunction, offering possible explanations for the clinical associations. This abstract-based account cannot establish that those processes explain cognitive decline in people or demonstrate an effective treatment strategy.

CHECK THE ORIGINAL

The original publication

The Influence of Insulin Resistance and Type 2 Diabetes on Cognitive Decline and Dementia in Parkinson's Disease: A Systematic Review.

Zeidan O, Jaragh N, Tama M et al.
Int J Mol Sci · 2025

PubMed ID
40869398
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.